0

Close
 
Upcoming Allied Market Research
2023
Nuclear Imaging System And Equipment Market

Nuclear Imaging System and Equipment Market

by Product (PET, SPECT, Planar scintigraphy), by Application (Oncology, Cardiology, Neurology, Others) and by End user (Imaging centers, Academic and research institute, Hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Medical Devices & Supplies
Report Code: A01214
Nov 2023 | Pages: NA
Tables: NA
Charts: NA

  • Formats*:

  • pdf

    Single User License, Five User
    License & Enterprise User License

  • xls

    Data Pack Excel License

  • ppt

    It comes with the additional cost
    of $2500.00 contact sales.
 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Nuclear Imaging System And Equipment Market

Request Now !

Nuclear imaging system basically involves the use of radioactive substances or tracers for the treatment of diseases. The radioactive substances are injected orally or intravenously and the imaging systems records the radiations emitted by these substances to create images of organs inside the human body. These generated images help the physician in better detection and diagnosis of the illness. The emergence of healthcare cum technology devices have addressed the increasing needs for better diagnostics. The technologically advanced imaging systems has surmounted the conventional systems in terms of precise and accurate images.

Rising cases of chronic diseases such as cancer, cardiac and neurological disorders, increasing awareness about the early diagnosis of disease and technological advancements have boosted the growth of the medical imaging systems market. Besides, rise in geriatric population, increasing expenditure on healthcare and growing demand for imaging system procedures are expected to further fuel the market growth. However, high cost of the imaging systems coupled with unfavorable reimbursement initiatives have restricted the growth of the market in developing regions.

Contemplating its segmentation, the market is divided on the basis of product type, application, end user and geography. The nuclear imaging system market is segmented on the grounds of product type into positron emission tomography (PET), single-photon emission computed tomography (SPECT) and planar scintigraphy systems. The PET and SPECT systems can be sub-segmented as hybrid PET, standalone PET, hybrid SPECT and standalone SPECT systems. On the basis of application, market is segmented into oncology, cardiology, neurology and other applications (which include urology, gastroenterology and thyroid related disorders). On the basis of end user market is divided into imaging centers, academic research institute, hospitals and others (which include pharma/biotech companies). Geographically the nuclear imaging systems and equipment report is segmented into North America, Asia Pacific, Europe and LAMEA.

Strategies such as product launch and collaborations have been adopted by the companies for market growth. GE Healthcare launched products such as Brivo XR118 (2015) and Brivo XR115 (November 2013) which is high frequency mobile generator to produce images of high quality. Besides, Philips also released its product such as Vereos Digital PET/CT, Ingenuity TF to improve the performance of PET/CT scanners.

The key players of this market include Royal Philips Healthcare, GE Healthcare, Siemens Healthcare, Digirad Corporation, DDD-Diagnostics A/S, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems, Ltd., SurgicEye GmbH and CMR Naviscan Corporation.

KEY MARKET BENEFITS:

  • The projections in the report are made by analyzing the current market trends and future market potential for the in terms of value.
  • The report analysis the segmentation of the nuclear imaging systems on the basis of end user and geography.
  • Analysis of the examination of the factors that curtail and bolster the market trends for nuclear imaging systems for example increased cases of chronic diseases aid the market growth.
  • The various players, leading companies their collaboration and their strategies to evolve the market growth rate.
  • The report also emphasizes on the current prevailing trends of the market and their estimations .
  • Region wise and country wise oral biologics market conditions are comprehensively analyzed in this report.

 Nuclear Imaging System and Equipment Market Report Highlights

Aspects Details
By Product
  • PET
  • SPECT
  • Planar scintigraphy
By Application
  • Oncology
  • Cardiology
  • Neurology
  • Others
By End user
  • Imaging centers
  • Academic and research institute
  • Hospitals
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, UAE, Rest of LAMEA)
Key Market Players Mediso Medical Imaging Systems, Ltd., SurgicEye GmbH, Siemens Healthcare, CMR Naviscan Corporation., Royal Philips Healthcare, Neusoft Medical Systems Co. Ltd., Digirad Corporation, Toshiba Medical Systems Corporation, GE Healthcare, DDD-Diagnostics A/S
 

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

    • 3.6. COVID-19 Impact Analysis

  • CHAPTER 4: NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY PRODUCT

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Product

    • 4.2. PET

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. SPECT

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Planar Scintigraphy

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

  • CHAPTER 5: NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY APPLICATION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Application

    • 5.2. Oncology

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Cardiology

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Neurology

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY END USER

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By End User

    • 6.2. Imaging Centers

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Academic And Research Institute

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Hospitals

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Others

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

  • CHAPTER 7: NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Product

      • 7.2.3. Market Size and Forecast, By Application

      • 7.2.4. Market Size and Forecast, By End User

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Nuclear Imaging System And Equipment Market

        • 7.2.6.1. Market Size and Forecast, By Product
        • 7.2.6.2. Market Size and Forecast, By Application
        • 7.2.6.3. Market Size and Forecast, By End User

      • 7.2.7. Canada Nuclear Imaging System And Equipment Market

        • 7.2.7.1. Market Size and Forecast, By Product
        • 7.2.7.2. Market Size and Forecast, By Application
        • 7.2.7.3. Market Size and Forecast, By End User

      • 7.2.8. Mexico Nuclear Imaging System And Equipment Market

        • 7.2.8.1. Market Size and Forecast, By Product
        • 7.2.8.2. Market Size and Forecast, By Application
        • 7.2.8.3. Market Size and Forecast, By End User

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Product

      • 7.3.3. Market Size and Forecast, By Application

      • 7.3.4. Market Size and Forecast, By End User

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Nuclear Imaging System And Equipment Market

        • 7.3.6.1. Market Size and Forecast, By Product
        • 7.3.6.2. Market Size and Forecast, By Application
        • 7.3.6.3. Market Size and Forecast, By End User

      • 7.3.7. Germany Nuclear Imaging System And Equipment Market

        • 7.3.7.1. Market Size and Forecast, By Product
        • 7.3.7.2. Market Size and Forecast, By Application
        • 7.3.7.3. Market Size and Forecast, By End User

      • 7.3.8. Italy Nuclear Imaging System And Equipment Market

        • 7.3.8.1. Market Size and Forecast, By Product
        • 7.3.8.2. Market Size and Forecast, By Application
        • 7.3.8.3. Market Size and Forecast, By End User

      • 7.3.9. Spain Nuclear Imaging System And Equipment Market

        • 7.3.9.1. Market Size and Forecast, By Product
        • 7.3.9.2. Market Size and Forecast, By Application
        • 7.3.9.3. Market Size and Forecast, By End User

      • 7.3.10. UK Nuclear Imaging System And Equipment Market

        • 7.3.10.1. Market Size and Forecast, By Product
        • 7.3.10.2. Market Size and Forecast, By Application
        • 7.3.10.3. Market Size and Forecast, By End User

      • 7.3.11. Russia Nuclear Imaging System And Equipment Market

        • 7.3.11.1. Market Size and Forecast, By Product
        • 7.3.11.2. Market Size and Forecast, By Application
        • 7.3.11.3. Market Size and Forecast, By End User

      • 7.3.12. Rest Of Europe Nuclear Imaging System And Equipment Market

        • 7.3.12.1. Market Size and Forecast, By Product
        • 7.3.12.2. Market Size and Forecast, By Application
        • 7.3.12.3. Market Size and Forecast, By End User

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Product

      • 7.4.3. Market Size and Forecast, By Application

      • 7.4.4. Market Size and Forecast, By End User

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Nuclear Imaging System And Equipment Market

        • 7.4.6.1. Market Size and Forecast, By Product
        • 7.4.6.2. Market Size and Forecast, By Application
        • 7.4.6.3. Market Size and Forecast, By End User

      • 7.4.7. Japan Nuclear Imaging System And Equipment Market

        • 7.4.7.1. Market Size and Forecast, By Product
        • 7.4.7.2. Market Size and Forecast, By Application
        • 7.4.7.3. Market Size and Forecast, By End User

      • 7.4.8. India Nuclear Imaging System And Equipment Market

        • 7.4.8.1. Market Size and Forecast, By Product
        • 7.4.8.2. Market Size and Forecast, By Application
        • 7.4.8.3. Market Size and Forecast, By End User

      • 7.4.9. South Korea Nuclear Imaging System And Equipment Market

        • 7.4.9.1. Market Size and Forecast, By Product
        • 7.4.9.2. Market Size and Forecast, By Application
        • 7.4.9.3. Market Size and Forecast, By End User

      • 7.4.10. Australia Nuclear Imaging System And Equipment Market

        • 7.4.10.1. Market Size and Forecast, By Product
        • 7.4.10.2. Market Size and Forecast, By Application
        • 7.4.10.3. Market Size and Forecast, By End User

      • 7.4.11. Thailand Nuclear Imaging System And Equipment Market

        • 7.4.11.1. Market Size and Forecast, By Product
        • 7.4.11.2. Market Size and Forecast, By Application
        • 7.4.11.3. Market Size and Forecast, By End User

      • 7.4.12. Malaysia Nuclear Imaging System And Equipment Market

        • 7.4.12.1. Market Size and Forecast, By Product
        • 7.4.12.2. Market Size and Forecast, By Application
        • 7.4.12.3. Market Size and Forecast, By End User

      • 7.4.13. Indonesia Nuclear Imaging System And Equipment Market

        • 7.4.13.1. Market Size and Forecast, By Product
        • 7.4.13.2. Market Size and Forecast, By Application
        • 7.4.13.3. Market Size and Forecast, By End User

      • 7.4.14. Rest of Asia Pacific Nuclear Imaging System And Equipment Market

        • 7.4.14.1. Market Size and Forecast, By Product
        • 7.4.14.2. Market Size and Forecast, By Application
        • 7.4.14.3. Market Size and Forecast, By End User

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Product

      • 7.5.3. Market Size and Forecast, By Application

      • 7.5.4. Market Size and Forecast, By End User

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Nuclear Imaging System And Equipment Market

        • 7.5.6.1. Market Size and Forecast, By Product
        • 7.5.6.2. Market Size and Forecast, By Application
        • 7.5.6.3. Market Size and Forecast, By End User

      • 7.5.7. South Africa Nuclear Imaging System And Equipment Market

        • 7.5.7.1. Market Size and Forecast, By Product
        • 7.5.7.2. Market Size and Forecast, By Application
        • 7.5.7.3. Market Size and Forecast, By End User

      • 7.5.8. Saudi Arabia Nuclear Imaging System And Equipment Market

        • 7.5.8.1. Market Size and Forecast, By Product
        • 7.5.8.2. Market Size and Forecast, By Application
        • 7.5.8.3. Market Size and Forecast, By End User

      • 7.5.9. UAE Nuclear Imaging System And Equipment Market

        • 7.5.9.1. Market Size and Forecast, By Product
        • 7.5.9.2. Market Size and Forecast, By Application
        • 7.5.9.3. Market Size and Forecast, By End User

      • 7.5.10. Argentina Nuclear Imaging System And Equipment Market

        • 7.5.10.1. Market Size and Forecast, By Product
        • 7.5.10.2. Market Size and Forecast, By Application
        • 7.5.10.3. Market Size and Forecast, By End User

      • 7.5.11. Rest of LAMEA Nuclear Imaging System And Equipment Market

        • 7.5.11.1. Market Size and Forecast, By Product
        • 7.5.11.2. Market Size and Forecast, By Application
        • 7.5.11.3. Market Size and Forecast, By End User

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning,2022

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Royal Philips Healthcare

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. GE Healthcare

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Siemens Healthcare

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Digirad Corporation

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. DDD-Diagnostics A/S

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Toshiba Medical Systems Corporation

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Neusoft Medical Systems Co. Ltd.

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Mediso Medical Imaging Systems, Ltd.

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. SurgicEye GmbH

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. CMR Naviscan Corporation.

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 2. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR PET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 3. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR SPECT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 4. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR PLANAR SCINTIGRAPHY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 5. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 6. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR ONCOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 7. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR CARDIOLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 8. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR NEUROLOGY, BY REGION, 2022-2032 ($MILLION)
  • TABLE 9. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 10. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 11. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR IMAGING CENTERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTE, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 15. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 18. NORTH AMERICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 19. NORTH AMERICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 20. U.S. NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 21. U.S. NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 22. U.S. NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 23. CANADA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 24. CANADA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 25. CANADA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 27. MEXICO NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 28. MEXICO NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 31. EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 32. EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 33. FRANCE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 36. GERMANY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 37. GERMANY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 38. GERMANY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 39. ITALY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 40. ITALY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 41. ITALY NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 42. SPAIN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 45. UK NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 46. UK NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 47. UK NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 48. RUSSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 49. RUSSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 50. RUSSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 51. REST OF EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 52. REST OF EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 53. REST OF EUROPE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 54. ASIA-PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 55. ASIA-PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 56. ASIA-PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 57. ASIA-PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 58. CHINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 59. CHINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 60. CHINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 61. JAPAN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 62. JAPAN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 63. JAPAN NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 64. INDIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 65. INDIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 66. INDIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 68. SOUTH KOREA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 69. SOUTH KOREA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 70. AUSTRALIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 71. AUSTRALIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 72. AUSTRALIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 73. THAILAND NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 74. THAILAND NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 75. THAILAND NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 76. MALAYSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 77. MALAYSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 78. MALAYSIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 79. INDONESIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 80. INDONESIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 81. INDONESIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 82. REST OF ASIA PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 83. REST OF ASIA PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 85. LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY REGION, 2022-2032 ($MILLION)
  • TABLE 86. LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 87. LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 88. LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 89. BRAZIL NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 90. BRAZIL NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 91. BRAZIL NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 92. SOUTH AFRICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 93. SOUTH AFRICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 95. SAUDI ARABIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 96. SAUDI ARABIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 97. SAUDI ARABIA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 98. UAE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 99. UAE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 100. UAE NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 101. ARGENTINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 102. ARGENTINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 103. ARGENTINA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 104. REST OF LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY PRODUCT, 2022-2032 ($MILLION)
  • TABLE 105. REST OF LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY APPLICATION, 2022-2032 ($MILLION)
  • TABLE 106. REST OF LAMEA NUCLEAR IMAGING SYSTEM AND EQUIPMENT, BY END USER, 2022-2032 ($MILLION)
  • TABLE 107. ROYAL PHILIPS HEALTHCARE: KEY EXECUTIVES
  • TABLE 108. ROYAL PHILIPS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 109. ROYAL PHILIPS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 110. ROYAL PHILIPS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 111. ROYAL PHILIPS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 112. GE HEALTHCARE: KEY EXECUTIVES
  • TABLE 113. GE HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 114. GE HEALTHCARE: OPERATING SEGMENTS
  • TABLE 115. GE HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 116. GE HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 117. SIEMENS HEALTHCARE: KEY EXECUTIVES
  • TABLE 118. SIEMENS HEALTHCARE: COMPANY SNAPSHOT
  • TABLE 119. SIEMENS HEALTHCARE: OPERATING SEGMENTS
  • TABLE 120. SIEMENS HEALTHCARE: PRODUCT PORTFOLIO
  • TABLE 121. SIEMENS HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 122. DIGIRAD CORPORATION: KEY EXECUTIVES
  • TABLE 123. DIGIRAD CORPORATION: COMPANY SNAPSHOT
  • TABLE 124. DIGIRAD CORPORATION: OPERATING SEGMENTS
  • TABLE 125. DIGIRAD CORPORATION: PRODUCT PORTFOLIO
  • TABLE 126. DIGIRAD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 127. DDD-DIAGNOSTICS A/S: KEY EXECUTIVES
  • TABLE 128. DDD-DIAGNOSTICS A/S: COMPANY SNAPSHOT
  • TABLE 129. DDD-DIAGNOSTICS A/S: OPERATING SEGMENTS
  • TABLE 130. DDD-DIAGNOSTICS A/S: PRODUCT PORTFOLIO
  • TABLE 131. DDD-DIAGNOSTICS A/S: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 132. TOSHIBA MEDICAL SYSTEMS CORPORATION: KEY EXECUTIVES
  • TABLE 133. TOSHIBA MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT
  • TABLE 134. TOSHIBA MEDICAL SYSTEMS CORPORATION: OPERATING SEGMENTS
  • TABLE 135. TOSHIBA MEDICAL SYSTEMS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 136. TOSHIBA MEDICAL SYSTEMS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 137. NEUSOFT MEDICAL SYSTEMS CO. LTD.: KEY EXECUTIVES
  • TABLE 138. NEUSOFT MEDICAL SYSTEMS CO. LTD.: COMPANY SNAPSHOT
  • TABLE 139. NEUSOFT MEDICAL SYSTEMS CO. LTD.: OPERATING SEGMENTS
  • TABLE 140. NEUSOFT MEDICAL SYSTEMS CO. LTD.: PRODUCT PORTFOLIO
  • TABLE 141. NEUSOFT MEDICAL SYSTEMS CO. LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 142. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: KEY EXECUTIVES
  • TABLE 143. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: COMPANY SNAPSHOT
  • TABLE 144. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: OPERATING SEGMENTS
  • TABLE 145. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: PRODUCT PORTFOLIO
  • TABLE 146. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 147. SURGICEYE GMBH: KEY EXECUTIVES
  • TABLE 148. SURGICEYE GMBH: COMPANY SNAPSHOT
  • TABLE 149. SURGICEYE GMBH: OPERATING SEGMENTS
  • TABLE 150. SURGICEYE GMBH: PRODUCT PORTFOLIO
  • TABLE 151. SURGICEYE GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 152. CMR NAVISCAN CORPORATION.: KEY EXECUTIVES
  • TABLE 153. CMR NAVISCAN CORPORATION.: COMPANY SNAPSHOT
  • TABLE 154. CMR NAVISCAN CORPORATION.: OPERATING SEGMENTS
  • TABLE 155. CMR NAVISCAN CORPORATION.: PRODUCT PORTFOLIO
  • TABLE 156. CMR NAVISCAN CORPORATION.: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET SEGMENTATION
  • FIGURE 2. GLOBAL NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET
  • FIGURE 3. SEGMENTATION NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALNUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET
  • FIGURE 11. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET SEGMENTATION, BY BY PRODUCT
  • FIGURE 12. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR PET, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 13. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR SPECT, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 14. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR PLANAR SCINTIGRAPHY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 15. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 16. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR ONCOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 17. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 18. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR NEUROLOGY, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 19. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 20. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET SEGMENTATION, BY BY END USER
  • FIGURE 21. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR IMAGING CENTERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 22. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR ACADEMIC AND RESEARCH INSTITUTE, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 23. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR HOSPITALS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 24. NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET FOR OTHERS, BY COUNTRY, 2022-2032 ($MILLION)
  • FIGURE 25. TOP WINNING STRATEGIES, BY YEAR, 2020-2022*
  • FIGURE 26. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2020-2022*
  • FIGURE 27. TOP WINNING STRATEGIES, BY COMPANY, 2020-2022*
  • FIGURE 28. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 29. COMPETITIVE DASHBOARD
  • FIGURE 30. COMPETITIVE HEATMAP: NUCLEAR IMAGING SYSTEM AND EQUIPMENT MARKET
  • FIGURE 31. Top player positioning, 2022
  • FIGURE 32. ROYAL PHILIPS HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 33. ROYAL PHILIPS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 34. ROYAL PHILIPS HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 35. GE HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 36. GE HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 37. GE HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 38. SIEMENS HEALTHCARE: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 39. SIEMENS HEALTHCARE: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 40. SIEMENS HEALTHCARE: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 41. DIGIRAD CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 42. DIGIRAD CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 43. DIGIRAD CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 44. DDD-DIAGNOSTICS A/S: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 45. DDD-DIAGNOSTICS A/S: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 46. DDD-DIAGNOSTICS A/S: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 47. TOSHIBA MEDICAL SYSTEMS CORPORATION: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 48. TOSHIBA MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 49. TOSHIBA MEDICAL SYSTEMS CORPORATION: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 50. NEUSOFT MEDICAL SYSTEMS CO. LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 51. NEUSOFT MEDICAL SYSTEMS CO. LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 52. NEUSOFT MEDICAL SYSTEMS CO. LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 53. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 54. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 55. MEDISO MEDICAL IMAGING SYSTEMS, LTD.: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 56. SURGICEYE GMBH: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 57. SURGICEYE GMBH: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 58. SURGICEYE GMBH: REVENUE SHARE, BY REGION, 2032 (%)
  • FIGURE 59. CMR NAVISCAN CORPORATION.: NET SALES, 2020-2022 ($MILLION)
  • FIGURE 60. CMR NAVISCAN CORPORATION.: REVENUE SHARE, BY SEGMENT, 2032 (%)
  • FIGURE 61. CMR NAVISCAN CORPORATION.: REVENUE SHARE, BY REGION, 2032 (%)

 
 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

PURCHASE OPTIONS

Call or Email us

U.S.-Canada Toll-free: +1-800-792-5285
Int'l : +1-503-894-6022
Europe : +44-845-528-1300
Email : help@alliedmarketresearch.com

Looking for Customization?

 Customization Request

Have a Question?

 Speak with Analyst

Any Confusion?

 Inquire Before Buying

Have a glance of the Report

  Enquiry Now

Purchase Full Report of
Nuclear Imaging System And Equipment Market

Start reading.
This Report and over 66,944+ more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,690
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  • Free industry update
    (Within 180 days)
  • Free report update in next update cycle
  • Data Pack
  • $3,930
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Single User
  • $5,820
  • Restricted to one authorized user
  • One print only
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle
  • Five Users
  • $6,540
  • Limited to five authorized users
  • Print upto five copies
  • Available in
    PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Enterprise
    License/PDF

  • $9,870
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  • Free industry update
    (Within 180 days)
  •   Free report update in next update cycle

  • Library
    Membership

  • $999 $ 1,175
    Per User/ Per month/ Billed annually
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

RELATED REPORTS
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

Get Industry Data Alerts

Why Allied Market Research?

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers